최근 제약·바이오 기업(상장사 163개)은 주가가 급상승하면서 투자자 보호 필요성이 커졌지만, 회계처리 문제 등이 해결되지 못했다.
Recently, as pharmaceutical and bio companies (163 listed companies) has skyrocketed, needs for protecting investor are emerging but their accounting problems weren't solved.